Skip to main content

Table 2 Wheezing study participants’ age-group at baseline and treatment arm in DeWorm3

From: Multiple overlapping risk factors for childhood wheeze among children in Benin

Age-group at Baseline

Intervention arm (community MDAa)

Control arm (school MDA)

MDA1 (06–2018)

MDA2 (11–2018)

MDA3 (06–2019)

MDA4 (11–2019)

MDA5 (06–2020)

MDA2 (11–2018)

MDA4 (11–2019)

PSACb

(1–4 years)

111/120

114/120

109/120

111/120

111/120

1/106d

106/106e

SACc

(5–14 years)

322/330

321/330

309/330

309/330

294/330

339/339¤

339/339e

  1. aMDA: Mass Drug Administration
  2. bPSAC: Pre-School Aged Children,
  3. cSAC: School-Aged Children
  4. dIn 2018, there were 106 PSAC aged 4 years in control clusters who were not eligible for treatment. One of them was treated by mistake during community MDA2
  5. eBecause individual treatment data were not available for MDA in control clusters, we assumed that all children were treated at school